RHUMBLINE ADVISERS

Position in PRLD — Prelude Therapeutics Inc

CIK 1115418 BOSTON, MA

Position in PRLD

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$117,654

+$105,751 QoQ

Shares Held

22,074

+42.4% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#43

of 75 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 30% Shared 0% None 70%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. PRLD ranks #269 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$117,654	22,074	+42.4%	Shares	Sole	2026-08-12
2025-03-31	$11,903	15,499	-90.7%	Shares	Sole	2025-05-29
2024-12-31	$212,708	166,830	+1289.8%	Shares	Sole	2025-05-29
2024-09-30	$24,848	12,004	-44.3%	Shares	Sole	2024-11-12
2024-06-30	$82,162	21,565	+1.9%	Shares	Sole	2024-08-01
2024-03-31	$100,326	21,166	+3.7%	Shares	Sole	2024-05-09
2023-12-31	$87,120	20,403	-39.7%	Shares	Sole	2024-02-08
2023-09-30	$104,488	33,815	+13.4%	Shares	Sole	2023-11-09
2023-06-30	$134,185	29,819	+196.7%	Shares	Sole	2023-08-08
2022-03-31	$69,345	10,050	+8.4%	Shares	Sole	2022-05-12
2021-09-30	$289,843	9,275	+5.7%	Shares	Sole	2021-11-12
2021-06-30	$251,228	8,775	-9.2%	Shares	Sole	2021-08-05
2021-03-31	$418,611	9,661	+1.2%	Shares	Sole	2021-05-06
2020-12-31	$683,016	9,546	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.